9-5 | Novartis will go before the Indian Supreme Court tomorrow in the latest attempt by the Swiss multinational pharmaceutical company to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusively patenting known medicines. If successful, the move would have a devastating impact on access to affordable medicines across the developing world, according to international humanitarian medical organisation Médecins Sans Frontières (MSF).
7-29 | Humanitarian crisis calls for extension of moratorium on deportationsMédecins Sans Frontières (MSF) is gravely concerned that South African authorities’ strategies to address migration do nothing to resolve the greater humanitarian crisis surrounding vulnerable migrants, refugees, and asylum seekers.
7-12 | Excluded countries should be ready to issue compulsory licences to access needed drugs An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with large numbers of people living with HIV, the international medical humanitarian organisation Médecins Sans Frontières (MSF) said today.
7-12 | Excluded countries should be ready to issue compulsory licences to access needed drugs An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with large numbers of people living with HIV, the international medical humanitarian organisation Médecins Sans Frontières (MSF) said today.
6-30 | Libya: Aid on the frontlineHaiti: resurgence of choleraJapan: Survivor traumaHIV/AIDS: ARVs for 15 millions patientsFrance: Dangerous amendments